Delivery Order SPE2DB24D3013-SPE2DB25FFKNW
Award Date
3/31/25
Potential Completion Date
4/1/25
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The delivery order has a firm fixed price of $10,957.52 and a completion date of May 12, 2025. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $16,818.10 and is a Firm Fixed Price Delivery Order that runs through September 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) with delivery orders for DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has a ceiling value of $2,861.25 and a completion date of June 4, 2025. It is a firm fixed-price delivery order contract, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,992.41, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of October 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,222.50 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used in the management of diabetes. The contract has an ultimate completion date of March 7, 2025. This contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,762.40, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of March 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $3,491.54 and a period of performance through March 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,376.58 firm fixed-price delivery order is for the supply of 4567408209 - DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used in the management of diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dapagliflozin 10 mg tablets, which are used to treat type 2 diabetes. The contract has a ceiling value of $13,655.93 and a completion date of July 12, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award, valued at $2,001.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. This is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...